Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research. Antibody treatment which activates the patient's own immune system ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...

Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...

Immunotherapy, or antibody treatment that activates the patient’s own immune system against cancer, is increasingly being ...

London: Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being studied as an alternative to chemotherapy and radiotherapy.

A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...